Page 93 - New epidemiological and PSMA-expression based paradigms in salivary gland tumors

Risk of breast cancer after a salivary gland tumor in the Netherlands
22 Moertel C, Elveback L. The association between salivary gland cancer and breast cancer. JAMA 1969; 210: 306-308
23 Dunn J, Kay U, Bragg, et al. Breast cancer risk following a major salivary gland carcinoma. Cancer 1972; 29: 1343-1346
24 Prior P, Waterhouse J. Second primary cancers in patients with tumours of the salivary glands. Br J Cancer 1977; 36: 362-368
25 Biggar R, Curtis R, Hoffman D, et al. Second primary malignancies following salivary gland cancers. Br J Cancer 1983; 47: 383-386
26 Abbey L, Schwab B, Landau G, et al. Incidence of second primary breast cancer among patients with a first primary salivary gland tumor. Cancer 1984; 54: 1439-1442
27 Sun EC, Curtis R, Melbye M GJ. Salivary gland cancer in the United States. Cancer Epidemiol Biomarkers Prev 1999; 8: 1095-1100
28 In der Maur CD, Klokman WJ, van Leeuwen FE, et al. Increased risk of breast cancer development after diagnosis of salivary gland tumour. Eur J Cancer 2005; 41: 1311-1315
29 Horn-Ross P, Morrow M, Ljung B. Menstrual and reproductive factors for salivary gland cancer risk in women. Epidemiology 1999; 10: 528-530
30 Yesensky J, Kyrillos A, Kuchta K, et al. Risk of Development of Second Primary Head and Neck Cancer following an Index Breast Cancer. Otolaryngol - Head Neck Surg 2018; 158: 303-308
31 Brenner H, Gefeller O, Hakulinen T. Period analysis for “up-to-date” cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer 2004; 40: 326-335
32 Breslow N, Day N. Statistical Methods in Cancer Research. Volume II--The Design and Analysis of Cohort Studies. Vol 82.
33 Dutch Cancer Registry (IKNL). https://www.cijfersoverkanker.nl/selecties/dataset_1/img5c52d02a1f- 8fa.
34 Breast Cancer Report; World Cancer Research Fund and American Institute for Cancer.
35 Brown SB HS. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers. Steroids
2015; 99 (Pt A): 8-10
36 Folkerd E, Dowsett M. Sex hormones and breast cancer risk and prognosis. Breast 2013; Suppl 2: S38-
43
37 Samavat H, Kurzer M. Estrogen metabolism and breast cancer. Cancer Lett 2015; 356: 231-243
38 Chuffa L, Lupi-Júnior L, Costa A, et al. The role of sex hormones and steroid receptors on female reproductive cancers. Steroids 2017; 118
39 Santen R, Yue W, Wang J. Estrogen metabolites and breast cancer. Steroids 2015; 99 (Pt A): 61-66
40 Simin J, Tamimi R, Lagergren J, et al. Menopausal hormone therapy and cancer risk: An overestimated
risk? Eur J Cancer 2017; 84: 60-68
41 World Health Organization IA for R on C. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 91: Combined Estrogen-Progestogen Contraceptives and Combined Estrogen- Progestogen Menopausal Therapy.; 2007.
42 Gierisch J, Coeytaux R, Urrutia R, et al. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev 2013; 22: 1931-1943
43 Lahmann P, Hoffmann K, Allen N, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 2004; 111: 762-771
44 Key T, Appleby P, Reeves G, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95: 1218-1226
45 Barrera J, Shroyer K, Said S, et al. Estrogen and progesterone receptor and p53 gene expression in adenoid cystic cancer. Head Neck Pathol 2008; 2: 13-18
46 Dori S, Trougouboff P, David R, et al. Immunohistochemical evaluation of estrogen and progesterone receptors in adenoid cystic carcinoma of salivary gland origin. Oral Oncol 2000; 36: 450-453
47 Nasser S, Faquin W, Dayal Y. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol 2003; 119: 801-806
5
91